Abstract
Human chylomicron triglyceride (TG) kinetics has been difficult to determine directly owing to technical limitations. This report describes a new method for studying chylomicron metabolism. Healthy volunteers (n=10) sipped a drink providing 175 mg fat·kg−1·h−1 for 7.5 h to produce a steady-state chylomicronemia. A commercial 10% intravenous lipid emulsion was labeled with [3H]triolein, purified by high-performance liquid chromatography, and sterilized. A trace amount of labeled emulsion was injected intravenously 30 min before (i.e., in the fasting state) and 5, 6, and 7 h after sipping began (i.e., triplicate determinations in the fed state). Chylomicron half-lives were calculated from the monoexponential decay curves, and apparent distribution volumes were estimated by back-extrapolation to time zero. Plasma and estimated chylomicron TG concentrations increased from 89±13 and 0.8±0.3 to 263±43 and 91±39 mg/dL (mean±SEM), respectively, with feeding. Tracer-determined chylomicron TG half-lives were 5.34±0.58 and 6.51±0.58 min during the fasting and fed states, respectively (P<0.01). The apparent distribution volume during the fasting state was 24% greater than plasma volume (4515±308 vs. 3630±78 mL, P<0.02), consistent with significant margination of lipid emulsion particles to endothelial binding sites. Margination was reduced during the fed state, suggesting that native chylomicrons competed with lipid emulsion particles for endothelial lipoprotein lipase. The results indicate that a radiolabeled commercial lipid emulsion is metabolized in a fashion similar to native chylomicron TG, and thus can be used to study chylomicron TG kinetics.
Similar content being viewed by others
Abbreviations
- HDL:
-
high density lipoprotein
- HPLC:
-
high-performance liquid chromatography
- LDL:
-
low density lipoprotein
- LpL:
-
lipoprotein lipase
- PL:
-
phospholipid
- TG:
-
triglyceride
- VLDL:
-
very low density lipoprotein
References
Sharrett, A.R., Chambless, L.E., Heiss, G., Patton, C.C., and Patsch, W. (1995) Association of Postprandial Triglyceride and Retinyl Palmitate Responses with Asymptomatic Carotid Artery Atherosclerosis in Middle-Aged Men and Women. The Atherosclerosis Risk in Communities (ARIC) Study, Arterioscler. Thromb. Vasc. Biol. 15, 2122–2129.
Karpe, F., Steiner, G., Uffelman, K., Olivecrona, T., and Hamsten, A. (1994) Postprandial Lipoproteins and Progression of Coronary Atherosclerosis, Atherosclerosis 106, 83–97.
Alaupovic, P., Mack, W.J., Knight-Gibson, C., and Hodis, H.N. (1997) The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography from a Controlled Clinical Trial, Arterioscler. Thromb. Vasc. Biol. 17, 715–722.
Weintraub, M., Charach, G., and Grosskopf, I. (1997) Disturbances in Dietary Fat Metabolism and Their Role in the Development of Atherosclerosis, Biomed. Pharmacotherap. 51, 311–313.
Karpe, F., Hellénius, M.-L., and Hamsten, A. (1999) Differences in Postprandial Concentrations of Very Low Density Lipoprotein and Chylomicron Remnants Between Normotriglyceridemic and Hypertriglyceridemic Men with and without Coronary Heart Disease, Metabolism 48, 301–307.
Nestel, P.J., Denborough, M., and O'Dea, K. (1962) Disposal of Human Chylomicrons Administered Intravenously in Ischaemic Heart Disease and Essential Hyperlipemia, Circ Res. 10, 786–791.
Grundy, S.M., and Mok, H.Y.I. (1976) Chylomicron Clearance in Normal and Hyperlipidemic Man, Metabolism 25, 1225–1239.
Cohen, J.C. (1989) Chylomicron Triglyceride Clearance: A Comparison of Three Assessment Methods, Am. J. Clin. Nutr. 49, 306–313.
Rossner, S. (1974) Studies on an Intravenous Fat Tolerance Test, Methodological, Experimental and Clinical Experiences with Intralipid(R), Acta Med. Scand. 564, 1–24.
Boivin, A., and Deshaies, Y. (1995) Dietary Rat Models in Which the Development of Hypertriglyceridemia and That of Insulin Resistance Are Dissociated, Metabolism: Clinical & Experimental 44, 1540–1547.
Seidner, D.L., Mascioli, E.A., Istfan, N.W., Porter, K.A., Selleck, K., Blackburn, G.L., and Bistrian, B.R. (1989) Effects of Long-Chain Triglyceride Emulsions on Reticuloendothelial System Function in Humans, JPEN. 13, 614–619.
Nakandakare, E.R., Lottenberg, S.A., Oliveira, H.C.F., Bertolami, M.C., Vasconcelos, K.S., Sperotto, G., and Quintão, E.C.R. (1994) Simultaneous Measurements of Chylomicron Lipolysis and Remnant Removal Using a Doubly Labeled Artificial Lipid Emulsion: Studies in Normolipidemic and Hyperlipidemic Subjects, J. Lipid Res. 35, 143–152.
Redgrave, T., Ly, H.L., Quintao, E., Ramberg, C.F., and Boston, R. (1993) Clearance from Plasma of Triacylglycerol and Cholesteryl Ester After Intravenous Injection of Chylomicron-Like Lipid Emulsions in Rats and Man, Biochem. J. 290, 843–847.
Oliveira, H., Hirata, M.H., Redgrave, T.G., and Maranhao, R. (1988) Competition Between Chylomicrons and Their Remnants for Plasma Removal: A Study with Artificial Emulsion Models of Chylomicrons, Biochim. Biophys. Acta 958, 211–217.
Ferezou, J., Lai, N.-T., Leray, C., Hajri, T., Frey, A., Cabaret, Y., Courtieu, J., Lutton, C., and Bach, A.C. (1994) Lipid Composition and Structure of Commercial Parenteral Emulsions, Biochim. Biophys. Acta, 1213, 149–158.
Park, Y.-S., Grellner, W.J., Harris, W.S., and Miles, J.M. (2000) A New Method for the Study of Chylomicron Kinetics in vivo, Am. J. Physiol. 279, E1258-E1263.
Fraser, R. (1970) Size and Lipid Composition of Chylomicrons of Different Svedberg Units of Flotation, J. Lipid Res. 11, 60–65.
Harris, W.S., and Connor, W.E. (1980) The Effects of Salmon Oil upon Plasma Lipids, Lipoproteins, and Triglyceride Clearance, Trans. Assoc. Am. Physic. 43, 148–155.
Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge, Clin. Chem. 19, 499–502.
Karpe, F., Olivecrona, T., Hamsten, A., and Hultin, M. (1997) Chylomicron/Chylomicron Remnant Turnover in Humans: Evidence for Margination of Chylomicrons and Poor Conversion of Larger to Smaller Chylomicron Remnants, J. Lipid Res. 38, 949–961.
Folch, J., Lees, M., and Sloane-Stanley, G.H. (1957), A Simple Method for the Isolation and Purification of Total Lipids from Animal Tissues, J. Biol. Chem. 226, 497–509.
Maranhão, R.C., Feres, M.C., Martins, M.T., Mesquita, C.H., Toffoletto, O., Vinagre, C.G.C., Gianinni, S.D., and Pileggi, F. (1996) Plasma Kinetics of a Chylomicron-Like Emulsion in Patients with Coronary Artery Disease, Atherosclerosis 126, 15–25.
Harris, W.S., Hustvedt, B.E., Hagen, E., Green, M.H., Lu, G., and Drevon, C.A. (1997) n−3 Fatty Acids and Chylomicron Metabolism in the Rat, J. Lipid Res. 38, 503–515.
Hultin, M., Carneheim, C., Rosenqvist, K., and Olivecrona, T. (1995) Intravenous Lipid Emulsions: Removal Mechanisms as Compared to Chylomicrons, J. Lipid Res. 36, 2174–2184.
Lutz, O., Meraihi, Z., Ferezou, J., Frey, A., Lutton, C., and Bach, A.C. (1990) The Mesophase of Parenteral Fat Emulsion Is Both Substrate and Inhibitor of Lipoprotein Lipase and Hepatic Lipase, Metab.: Clin. Exp. 39, 1225–1231.
Hajri, T., Ferezou, J., and Lutton, C. (1990) Effects of Intravenous Infusions of Commercial Fat Emulsions (Intralipid 10 or 20%) on Rat Plasma Lipoproteins: Phospholipids in Excess Are the Main Precursors of Lipoprotein-X-Like Particles, Biochim. Biophys. Acta 1047, 121–130.
Quarfordt, S.H., and Goodman, D.S. (1966) Heterogeneity in the Rate of Plasma Clearance of Chylomicrons of Different Size, Biochim. Biophys. Acta 116, 382–385.
Eckel, R.H., Goldberg, I.J., Steiner, L., Yost, T.J., and Paterniti, J.R., Jr. (1988) Plasma Lipolytic Activity: Relationship to Postheparin Lipolytic Activity and Evidence for Metabolic Regulation, Diabetes 37, 610–615.
Brunzell, J.D., Hazzard, W.R., Porte, D., Jr., and Bierman, E.L. (1973) Evidence for a Common, Saturable, Triglyceride Removal Mechanism for Chylomicrons and Very Low Density Lipoproteins in Man, J. Clin. Invest. 52, 1578–1585.
Karpe, F., Olivecrona, T., Walldius, G., and Hamsten, A. (1992) Lipoprotein Lipase in Plasma After an Oral Fat Load: Relation to Free Fatty Acids, J. Lipid Res. 33, 975–984.
Peterson, J., Bihain, B.E., Bengtsson-Olivecrona, G., Deckelbaum, R.J., Carpentier, Y., and Olivecrona, T. (1990) Fatty Acid Control of Lipoprotein Lipase: A Link Between Energy Metabolism and Lipid Transport, Proc. Natl. Acad. Sci. USA 87, 909–913.
Mann, C.J., Khallou, J., Chevreuil, O., Troussard, A.A., Guermani, L.M., Launay, K., Delplanque, B., Yen, F.T., and Bihain, B.E. (1995) Mechanism of Activation and Functional Significance of the Lipolysis-Stimulated Receptor, Biochem. 34, 10421–10431.
Lewis, B., Chait, A., February, A.W., and Mattock, M. (1973) Functional Overlap Between “Chylomicra” and “Very Low Density Lipoproteins” of Human Plasma During Alimentary Lipaemia, Atherosclerosis 17, 455–462.
Karpe, F., Steiner, A., Olivecrona, T., Carlson, L.A., and Hamsten, A. (1993) Metabolism of Triglyceride-Rich Lipoproteins During Alimentary Lipemia, J. Clin. Invest. 91, 748–759.
Schneeman, B.O., Kotite, L., Todd, K.M., and Havel, R.J. (1993) Relationships Between the Responses of Triglyceride-Rich Lipoproteins in Blood Plasma Containing Apolipoproteins B-48 and B-100 to a Fat-Containing Meal in Normolipidemic Humans, Proc. Natl. Acad. Sci. USA 90, 2069–2073.
Cohn, J.S., Johnson, E.J., Millar, J.S., Cohn, S.D., Milne, R.W., Marcel, Y.L., Russell, R.M., and Schaefer, E.J. (1993) Contribution of ApoB-48 and ApoB-100 Triglyceride-Rich Lipoproteins (TRL) to Postprandial Increases in the Plasma Concentration of TRL Triglycerides and Retinyl Esters, J. Lipid Res. 34, 2033–2040.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Park, Y., Damron, B.D., Miles, J.M. et al. Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion. Lipids 36, 115–120 (2001). https://doi.org/10.1007/s11745-001-0696-6
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-001-0696-6